Search results
Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy
Author(s):
Long Peng
,
Tao Zeng
,
Enxi Quan
,
et al
Added:
11 months ago
Original Research
Cardiac Amyloidosis: Everywhere, but Nowhere
Author(s):
Aqtab Mazhar Alias
,
Raja Ezman Raja Shariff
,
Norashikin Saidon
,
et al
Added:
2 years ago
Case Report
Iron Deficiency in LVAD Patients
Author(s):
William Herrik Nielsen
,
Finn Gustafsson
Added:
1 year ago
Review Article
Author(s):
Harriette Van Spall
,
Udo Bavendiek
Added:
7 months ago
ESC Congress 2025 - Digitoxin reduced the risk of all-cause mortality and hospitalisation in patients with worsening heart failure.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Udo Bavendiek to explore the DIGIT-HF trial, investigating whether digitoxin can improve outcomes in patients with advanced chronic heart failure and reduced ejection fraction.This landmark study…
View more
Added:
6 months ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has…
View more
Supportive Care in Pulmonary Embolism
Author(s):
Sylwia Sławek-Szmyt
,
Aleksander Araszkiewicz
Added:
2 months ago
Review Article
Author(s):
Finn Gustafsson
Added:
1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two…
View more
Author(s):
Michael R Zile
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
Cardio-obstetrics in the CICU: An Introductory Guide
Author(s):
Jenna Skowronski
,
Eleanor Christenson
,
Kayle Shapero
,
et al
Added:
1 year ago
Review Article
Author(s):
Hanad Bashir
,
Pooja Prasad
,
Cali Clark
,
et al
Added:
1 year ago